RENE
RODRIGUEZ GONZALEZ
Investigador/a
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (24)
2024
2023
-
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Nature Communications, Vol. 14, Núm. 1
-
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
Biomedicine and Pharmacotherapy, Vol. 162
-
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma
Redox Biology, Vol. 62
-
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells
Free Radical Biology and Medicine, Vol. 209, pp. 127-134
-
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Biomedicines, Vol. 11, Núm. 1
2022
-
Addressing Doxorubicin Resistance in Bone Sarcomas using Novel Drug‐Resistant Models
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
Proof of concept for the use of trained sniffer dogs to detect osteosarcoma
Scientific Reports, Vol. 12, Núm. 1
2021
-
Cancer stem cells as a source of drug resistance in bone sarcomas
Journal of Clinical Medicine, Vol. 10, Núm. 12
-
Mithramycin delivery systems to develop effective therapies in sarcomas
Journal of Nanobiotechnology, Vol. 19, Núm. 1
-
Nano-encapsulation of mithramycin in transfersomes and polymeric micelles for the treatment of sarcomas
Journal of Clinical Medicine, Vol. 10, Núm. 7
2020
-
GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β
Cell Death and Disease, Vol. 11, Núm. 11
-
Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL
Blood, Vol. 136, Núm. 3, pp. 313-327
-
Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications
Cancers, Vol. 12, Núm. 4
2019
-
New chondrosarcoma cell lines with preserved stem cell properties to study the genomic drift during in vitro/in vivo growth
Journal of Clinical Medicine, Vol. 8, Núm. 4
-
The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042
Journal of Clinical Medicine, Vol. 8, Núm. 8
-
The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma
Cancers, Vol. 11, Núm. 11
-
The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas
International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266
-
The novel role of SOX2 as an early predictor of cancer risk in patients with laryngeal precancerous lesions
Cancers, Vol. 11, Núm. 3
2018
-
Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients
Journal of Clinical Medicine, Vol. 7, Núm. 12